Amanda Hanson, Kutlu Elpek, Ellen Duong, Lindsey Shallberg, Martin Fan, Calvin Johnson, Matthew Wallace, George R. Mabry, Stephen Sazinsky, Lauren Pepper, Chengyi J. Shu, Sriram Sathyanarayanan, Sarah Zuerndorfer, Tyler Simpson, Monica Gostissa, Michael Briskin, Deborah Law, Jennifer Michaelson, Christopher J. Harvey. ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc crosslinking for optimal T cell activation and antitumor immunity in preclinical models. Published PLOS ONE (September 2020).